SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: PAL who wrote (571)6/24/1998 2:03:00 PM
From: JGoren  Respond to of 1906
 
Medicare will pay for Amgen's top drug, the anemia treatment Epogen, even if it boosts a patient's red blood cells over an earlier limit. That's reason for performance today, according to Bloomberg.